REGENERON PHARMACEUTICALS, INC.

REGN

—

Advanced chart & tools →

REGENERON PHARMACEUTICALS, INC.REGN

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$41.48

Dividend yield

0.00%

Dividend / share

$0.88

Revenue

$14.34B

Net income

$4.50B

Net margin

31.4%

Gross margin

—

Dividends & financials

REGENERON PHARMACEUTICALS, INC. (REGN) reported revenue of $14.34B and net income of $4.50B, or $41.48 per diluted share. It pays an annual dividend of $0.88 per share — a yield of 0.00% at the current price. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.